Y-Mabs Therapeutics Inc (YMAB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2022 | 09-2022 | 06-2022 | 03-2022 | 12-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -95,568 | -96,725 | -69,199 | -28,068 | -55,275 |
| Depreciation Amortization | 839 | 609 | 383 | 195 | 782 |
| Accounts receivable | -4,819 | -1,539 | 504 | -1,612 | -7,712 |
| Accounts payable and accrued liabilities | -919 | 171 | -2,261 | 1,109 | 4,180 |
| Other Working Capital | -10,371 | 3,093 | 334 | -2,454 | -7,284 |
| Other Operating Activity | 34,917 | 27,131 | 22,214 | 5,905 | -37,247 |
| Operating Cash Flow | $-75,921 | $-67,260 | $-48,025 | $-24,925 | $-102,556 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | N/A | N/A | N/A | -667 |
| Purchase Sale Intangibles | N/A | N/A | N/A | N/A | -300 |
| Other Investing Activity | 0 | 0 | 0 | 0 | 61,710 |
| Investing Cash Flow | $N/A | $N/A | $N/A | $N/A | $61,043 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 84 | 84 | 32 | 32 | 108,314 |
| Financing Cash Flow | $84 | $84 | $32 | $32 | $108,314 |
| Exchange Rate Effect | 35 | 138 | 94 | 53 | 129 |
| Beginning Cash Position | 181,564 | 181,564 | 181,564 | 181,564 | 114,634 |
| End Cash Position | 105,762 | 114,526 | 133,665 | 156,724 | 181,564 |
| Net Cash Flow | $-75,802 | $-67,038 | $-47,899 | $-24,840 | $66,930 |
| Free Cash Flow | |||||
| Operating Cash Flow | -75,921 | -67,260 | -48,025 | -24,925 | -102,556 |
| Capital Expenditure | N/A | N/A | N/A | N/A | -667 |
| Free Cash Flow | -75,921 | -67,260 | -48,025 | -24,925 | -103,223 |